👀‼️Serious Side Effects from GLP-1 drugs.
One in eight Americans is currently taking a GLP-1 drug, and the safety picture keeps getting worse. A new study analyzing five years of medical records from over 146,000 adults found GLP-1 users had a 30% higher chance of osteoporosis, a 100% higher chance of osteomalacia, and a 12% higher risk of gout compared to non-users. Researchers aren't yet sure why the drugs may be causing bone loss. It could be nutrient depletion from dramatically reduced appetite, or bones simply adapting to the lower body weight. What they do know is there is no long-term safety data for taking these drugs for 5, 10, or more years. And a separate review published this month found that 60% of lost weight returns within a year of stopping the drug, with projections pointing to a 75% plateau. Researchers are openly wondering whether the weight regained is disproportionately fat, leaving users worse off than when they started. The answer from some health professionals? Stay on the drug forever. Meanwhile, the FDA issued a formal warning letter to Novo Nordisk (the maker of Ozempic and Wegovy) for failing to report deaths to the agency as required. Two deaths were not reported at all. A third, involving a patient who died by suicide, was submitted late and only after an FDA inspection raised the issue. The suicide warning that was previously on semaglutide labels has since been quietly removed. Gastroparesis. Blindness. Bone loss. Gout. Unreported deaths. The chance there are serious mental health risks... This is the drug one in eight Americans is currently taking. Full story found here. Study reference found here. Best alternative found here.